581 related articles for article (PubMed ID: 9605165)
61. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.
Jimenez-Lucho VE; Joiner KA; Foulds J; Frank MM; Leive L
J Immunol; 1987 Aug; 139(4):1253-9. PubMed ID: 2440949
[TBL] [Abstract][Full Text] [Related]
62. Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component.
Lambris JD; Lao Z; Oglesby TJ; Atkinson JP; Hack CE; Becherer JD
J Immunol; 1996 Jun; 156(12):4821-32. PubMed ID: 8648130
[TBL] [Abstract][Full Text] [Related]
63. Structure of C3b in complex with CRIg gives insights into regulation of complement activation.
Wiesmann C; Katschke KJ; Yin J; Helmy KY; Steffek M; Fairbrother WJ; McCallum SA; Embuscado L; DeForge L; Hass PE; van Lookeren Campagne M
Nature; 2006 Nov; 444(7116):217-20. PubMed ID: 17051150
[TBL] [Abstract][Full Text] [Related]
64. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T
J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357
[TBL] [Abstract][Full Text] [Related]
65. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.
Huemer HP; Wang Y; Garred P; Koistinen V; Oppermann S
Immunology; 1993 Aug; 79(4):639-47. PubMed ID: 8406590
[TBL] [Abstract][Full Text] [Related]
66. C3 nephritic factor protects bound C3bBb from cleavage by factor I and human erythrocytes.
Mold C; Medof ME
Mol Immunol; 1985 May; 22(5):507-12. PubMed ID: 3848661
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
Medof ME; Kinoshita T; Nussenzweig V
J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
[TBL] [Abstract][Full Text] [Related]
68. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
[TBL] [Abstract][Full Text] [Related]
69. Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.
Pangburn MK; Schreiber RD; Trombold JS; Müller-Eberhard HJ
J Exp Med; 1983 Jun; 157(6):1971-80. PubMed ID: 6222136
[TBL] [Abstract][Full Text] [Related]
70. Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact.
Pryzdial EL; Isenman DE
J Biol Chem; 1987 Feb; 262(4):1519-25. PubMed ID: 3643213
[TBL] [Abstract][Full Text] [Related]
71. Glycosylated and nonglycosylated complement control protein of the lister strain of vaccinia virus.
Meseda CA; Kuhn J; Atukorale V; Campbell J; Weir JP
Clin Vaccine Immunol; 2014 Sep; 21(9):1330-8. PubMed ID: 25030055
[TBL] [Abstract][Full Text] [Related]
72. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
74. Trypanosoma brucei Invariant Surface gp65 Inhibits the Alternative Pathway of Complement by Accelerating C3b Degradation.
Lorentzen J; Olesen HG; Hansen AG; Thiel S; Birkelund S; Andersen CBF; Andersen GR
J Immunol; 2023 Sep; 211(5):862-873. PubMed ID: 37466368
[TBL] [Abstract][Full Text] [Related]
75. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
Brodbeck WG; Mold C; Atkinson JP; Medof ME
J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
[TBL] [Abstract][Full Text] [Related]
76. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
77. Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules.
Yadav VN; Pyaram K; Ahmad M; Sahu A
J Immunol; 2012 Aug; 189(3):1431-9. PubMed ID: 22732591
[TBL] [Abstract][Full Text] [Related]
78. Regulatory system of guinea-pig complement C3b: tests for compatibility of guinea-pig factors H and I with human factors.
Seya T; Okada M; Hazeki K; Nagasawa S
Mol Immunol; 1991; 28(4-5):375-82. PubMed ID: 1829503
[TBL] [Abstract][Full Text] [Related]
79. A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism.
Rodriguez E; Nan R; Li K; Gor J; Perkins SJ
J Biol Chem; 2015 Jan; 290(4):2334-50. PubMed ID: 25488663
[TBL] [Abstract][Full Text] [Related]
80. Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies.
Ramadass M; Ghebrehiwet B; Smith RJ; Kew RR
J Immunol; 2014 Feb; 192(3):1220-30. PubMed ID: 24367026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
